These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 27587404)

  • 1. Molecular mechanisms of Ebola pathogenesis.
    Rivera A; Messaoudi I
    J Leukoc Biol; 2016 Nov; 100(5):889-904. PubMed ID: 27587404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebola Virus: Pathogenesis and Countermeasure Development.
    Furuyama W; Marzi A
    Annu Rev Virol; 2019 Sep; 6(1):435-458. PubMed ID: 31567063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of ebola virus disease.
    Kilgore PE; Grabenstein JD; Salim AM; Rybak M
    Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebola Virus Transmission Caused by Persistently Infected Survivors of the 2014-2016 Outbreak in West Africa.
    Subissi L; Keita M; Mesfin S; Rezza G; Diallo B; Van Gucht S; Musa EO; Yoti Z; Keita S; Djingarey MH; Diallo AB; Fall IS
    J Infect Dis; 2018 Nov; 218(suppl_5):S287-S291. PubMed ID: 29920602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Impact of Sexual Transmission on Ebola Virus Epidemiology: Sierra Leone as a Case Study.
    Abbate JL; Murall CL; Richner H; Althaus CL
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004676. PubMed ID: 27135922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Outbreak of Ebola Virus Disease in the Lassa Fever Zone.
    Goba A; Khan SH; Fonnie M; Fullah M; Moigboi A; Kovoma A; Sinnah V; Yoko N; Rogers H; Safai S; Momoh M; Koroma V; Kamara FK; Konowu E; Yillah M; French I; Mustapha I; Kanneh F; Foday M; McCarthy H; Kallon T; Kallon M; Naiebu J; Sellu J; Jalloh AA; Gbakie M; Kanneh L; Massaly JL; Kargbo D; Kargbo B; Vandi M; Gbetuwa M; Gevao SM; Sandi JD; Jalloh SC; Grant DS; Blyden SO; Crozier I; Schieffelin JS; McLellan SL; Jacob ST; Boisen ML; Hartnett JN; Cross RW; Branco LM; Andersen KG; Yozwiak NL; Gire SK; Tariyal R; Park DJ; Haislip AM; Bishop CM; Melnik LI; Gallaher WR; Wimley WC; He J; Shaffer JG; Sullivan BM; Grillo S; Oman S; Garry CE; Edwards DR; McCormick SJ; Elliott DH; Rouelle JA; Kannadka CB; Reyna AA; Bradley BT; Yu H; Yenni RE; Hastie KM; Geisbert JB; Kulakosky PC; Wilson RB; Oldstone MB; Pitts KR; Henderson LA; Robinson JE; Geisbert TW; Saphire EO; Happi CT; Asogun DA; Sabeti PC; Garry RF;
    J Infect Dis; 2016 Oct; 214(suppl 3):S110-S121. PubMed ID: 27402779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 8. Ebola virus outbreak, updates on current therapeutic strategies.
    Elshabrawy HA; Erickson TB; Prabhakar BS
    Rev Med Virol; 2015 Jul; 25(4):241-53. PubMed ID: 25962887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ebola virus circulation in Africa: a balance between clinical expression and epidemiological silence.
    Gonzalez JP; Herbreteau V; Morvan J; Leroy EM
    Bull Soc Pathol Exot; 2005 Sep; 98(3):210-7. PubMed ID: 16267963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ebola Virus Infection Associated with Transmission from Survivors.
    Den Boon S; Marston BJ; Nyenswah TG; Jambai A; Barry M; Keita S; Durski K; Senesie SS; Perkins D; Shah A; Green HH; Hamblion EL; Lamunu M; Gasasira A; Mahmoud NO; Djingarey MH; Morgan O; Crozier I; Dye C
    Emerg Infect Dis; 2019 Feb; 25(2):249-255. PubMed ID: 30500321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confronting Ebola as a Sexually Transmitted Infection.
    Fischer WA; Wohl DA
    Clin Infect Dis; 2016 May; 62(10):1272-6. PubMed ID: 26936667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
    Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
    Front Immunol; 2021; 12():703986. PubMed ID: 34484200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inequitable access to Ebola vaccines and the resurgence of Ebola in Africa: A state of arts review.
    Abdul-Rahman T; Lawal L; Meale E; Ajetunmobi OA; Toluwalashe S; Alao UH; Ghosh S; Garg N; Aborode AT; Wireko AA; Mehta A; Sikora K
    J Med Virol; 2023 Aug; 95(8):e28986. PubMed ID: 37534818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.
    Dhama K; Karthik K; Khandia R; Chakraborty S; Munjal A; Latheef SK; Kumar D; Ramakrishnan MA; Malik YS; Singh R; Malik SVS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():1803. PubMed ID: 30147687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola haemorrhagic fever virus: pathogenesis, immune responses, potential prevention.
    Marcinkiewicz J; Bryniarski K; Nazimek K
    Folia Med Cracov; 2014; 54(3):39-48. PubMed ID: 25694094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and Management of the 2013-16 West African Ebola Outbreak.
    Boisen ML; Hartnett JN; Goba A; Vandi MA; Grant DS; Schieffelin JS; Garry RF; Branco LM
    Annu Rev Virol; 2016 Sep; 3(1):147-171. PubMed ID: 27578439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on West Africa Ebola Virus Disease Outbreak, 2013-2016.
    Spengler JR; Ervin ED; Towner JS; Rollin PE; Nichol ST
    Emerg Infect Dis; 2016 Jun; 22(6):956-63. PubMed ID: 27070842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
    Stock I
    Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola virus disease and the veterinary perspective.
    Gumusova S; Sunbul M; Leblebicioglu H
    Ann Clin Microbiol Antimicrob; 2015 May; 14():30. PubMed ID: 26018030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced evolutionary rate in reemerged Ebola virus transmission chains.
    Blackley DJ; Wiley MR; Ladner JT; Fallah M; Lo T; Gilbert ML; Gregory C; D'ambrozio J; Coulter S; Mate S; Balogun Z; Kugelman J; Nwachukwu W; Prieto K; Yeiah A; Amegashie F; Kearney B; Wisniewski M; Saindon J; Schroth G; Fakoli L; Diclaro JW; Kuhn JH; Hensley LE; Jahrling PB; Ströher U; Nichol ST; Massaquoi M; Kateh F; Clement P; Gasasira A; Bolay F; Monroe SS; Rambaut A; Sanchez-Lockhart M; Scott Laney A; Nyenswah T; Christie A; Palacios G
    Sci Adv; 2016 Apr; 2(4):e1600378. PubMed ID: 27386513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.